NEU 6.41% $15.27 neuren pharmaceuticals limited

Ann: Neuren approaching key milestones in Q4 2019, page-141

  1. 6,170 Posts.
    lightbulb Created with Sketch. 1643
    Medium term the on screen buy/sell ratios oscillate uniformly. IMO, reason being the stock is illiquid and a market maker has free rein to gradually accumulate (certainly over the past little while).

    When she's a-gonna pop (if it in fact does) is anybody's guess, but current action does not give much of a clue to timeline.

    That will be fundamentals driven and there is plenty of potential ammo in the pipeline. Let's wait and see.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.